ESOPJun 9, 2026, 04:06 PM
BioCryst Grants Equity Awards to 9 New Hires
AI Summary
BioCryst Pharmaceuticals announced that its compensation committee granted equity awards to nine newly-hired employees. These awards, totaling 33,950 stock options and 80,650 restricted stock units (RSUs), were granted on June 1, 2026, as inducements for their employment. The stock options have an exercise price of $8.57 per share and both options and RSUs vest in four equal annual installments.
Key Highlights
- BioCryst granted equity awards to 9 newly-hired employees.
- Awards include 33,950 stock options and 80,650 restricted stock units.
- Stock options have an exercise price of $8.57 per share.
- Awards vest in four equal annual installments.
- Granted on June 1, 2026, as employment inducements.
Price Impact
More from BCRX
Business UpdateMay 13, 7:01 AM
BioCryst to Present New HAE Real-World Evidence at ISPOR 2026
Quarterly ResultMay 6, 4:14 PM
BioCryst Reports Q1 Net Loss of $721.8M Due to Astria Acquisition
Quarterly ResultMay 6, 7:03 AM
BioCryst Licenses Navenibart European Rights for $70M Upfront; Q1 ORLADEYO Revenue $148.3M